Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the United States and Australia.

Jessica L HardingJedidiah I MortonJonathan E ShawRachel E PatzerStephen P McDonaldDianna J Magliano

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)

Excess mortality for people with ESKD-DM treated with dialysis or transplant has decreased in the US and Australia, but progress has stalled from ∼2013 in the US. Nevertheless, mortality remains more than nine times higher in ESKD-DM vs. the general population, with important variations by subgroups. Given the increasing burden of diabetes in the population, a focus on reducing excess mortality risk in the ESKD-DM population is needed.

Keyphrases

glycemic control
cardiovascular events
type diabetes
cardiovascular disease
risk factors
chronic kidney disease
coronary artery disease
end stage renal disease